Clinical Trials Directory

Trials / Completed

CompletedNCT01215370

Pea Protein and Postprandial Response (PEA)

Effect of Arginine-rich Dietary Protein on Postprandial Metabolism, Inflammation and Endothelial Function

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Wageningen University · Academic / Other
Sex
Male
Age
45 Years – 70 Years
Healthy volunteers
Accepted

Summary

The main objective is to investigate the postprandial effect of arginine-rich protein (i.e. pea-protein) on metabolic control, inflammation and endothelial function after a high-fat meal in subjects with characteristics of the metabolic syndrome.

Detailed description

Arginine is potential interesting considering the metabolic syndrome. Studies so far indicated both long-term effects, as well as acute - postprandial - actions; especially when metabolism is already challenged, e.g. in diabetic patients or after a high-fat meal. If arginine-rich proteins are equally effective is not known. Therefore we are interested in the effect of (arginine rich) protein on postprandial (dys)metabolism, inflammation and endothelial function, within 6 hours after a meal.

Conditions

Interventions

TypeNameDescription
OTHERHigh-fat shake with Pea proteinShake containing 95 gram of fat, additive 30 gram pea protein
OTHERHigh-fat shake with Pea protein hydrolysateShake containing 95 gram of fat, additive 30 gram gluten protein hydrolysate
OTHERHigh-fat shake - ControlShake containing 95 gram of fat, no protein additive
OTHERHigh-fat shake with Gluten proteinShake containing 95 gram of fat, additive 30 gram gluten protein.
OTHERHigh-fat shake with Gluten protein hydrolysateShake containing 95 gram of fat, additive 30 gram gluten gluten hydrolysate

Timeline

Start date
2010-09-01
Primary completion
2011-01-01
Completion
2011-01-01
First posted
2010-10-06
Last updated
2011-09-07

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01215370. Inclusion in this directory is not an endorsement.